Record Detail

Introduction Sleeve gastrectomy (LSG) is one of the most
popular bariatric procedures. We present our long-term results
regarding weight loss, comorbidities, and gastric reflux
disease.
Material and Methods We identified patients who underwent
LSG in our institution between 2006 and 2009. We revised the
data, and the patients with outdated contact details were
tracked with the national health insurance database and social
media (facebook). Each of the identified patients was asked to
complete an online or telephone survey covering, among
others, their weight and comorbidities. On that basis, we calculated
the percent total weight loss (%TWL) and percent
excess weight loss (%EWL), along with changes in body mass
index (ΔBMI). Satisfactory weight loss was set at >50% EWL
(for BMI = 25 kg/m2
). We evaluated type 2 diabetes (T2DM)
and arterial hypertension (AHT) based on the pharmacological
therapy. GERD presence was evaluated by the typical
symptoms and/or proton pump inhibitor (PPI) therapy.
Results One hundred twenty-seven patients underwent LSG
between 2006 and 2009. One hundred twenty patients were
qualified for this study. Follow-up data was available for 100
participants (47 female, 53 male). Median follow-up period
reached 8.0 years (from 7.1 to 10.7). Median BMI upon qualification
for LSG was 51.6 kg/m2
. Sixteen percent of patients
required revisional surgery over the years (RS group), mainly
because of insufficient weight loss (14 Roux-Y gastric bypass—LRYGB;
one mini gastric bypass, one gastric banding).
For the LSG (LSG group n = 84), the mean %EWL was
51.1% (±22.3), median %TWL was 23.5% (IQR 17.7–
33.3%), and median ΔBMI was 12.1 kg/m2 (IQR 8.2–17.2).
Fifty percent (n = 42) of patients achieved the satisfactory
%EWL of 50%. For RS group, the mean %EWL was 57.8%
(±18.2%) and median %TWL reached 33% (IQR 27.7–
37.9%). Sixty-two percent (n = 10) achieved the satisfactory
weight loss. Fifty-nine percent of patients reported improvement
in AHT therapy, 58% in T2DM. After LSG, 60%
(n = 60) of patients reported recurring GERD symptoms and
44% were treated with proton pomp inhibitors (PPI). In 93%
of these cases, GERD has developed de novo.
Conclusions Isolated LSG provides fairly good effects in a
long-term follow-up with mean %EWL at 51.1%. Sixteen
percent of patients require additional surgery due to insufficient
weight loss. More than half of the subjects observe improvement
in AHT and T2DM. Over half of the patients complain
of GERD sy